Global Sterile Injectable CDMO Market Projected to Surge to USD 33.7 Billion by 2034

Future Market Insights (FMI), a leading provider of market research, has unveiled its latest industry analysis indicating a robust trajectory for the global sterile injectable (CDMO) market. According to the report, the market was valued at approximately USD 10.1 billion in 2023 and is poised to witness a remarkable Compound Annual Growth Rate (CAGR) of …

Global Fluorescence-Guided Surgery System Market Projected to Reach USD 468 Million by 2034

The global fluorescence-guided surgery system market is poised for remarkable growth, with projections from Future Market Insights (FMI) indicating a surge to USD 110.8 million by 2024 and an impressive USD 468 million by 2034. FMI’s latest forecast suggests a robust Compound Annual Growth Rate (CAGR) of 15.5% from 2024 to 2034, underlining the sector’s …

Global Hydroxyzine Market Expected to Surge, Reaching USD 1430 Million by 2034

The global hydroxyzine market is set to witness substantial growth, with an estimated value of USD 829.9 million in 2024, projected to soar to USD 1430 million by 2034. This surge is attributed to the escalating demand driven by the rising prevalence of allergic diseases and anxiety disorders worldwide. According to recent market analysis, the …

Global Cord Blood Product Market Projected to Reach USD 1,341.7 Million by 2034

The global cord blood product market is set to experience substantial growth over the coming decade, with market size expected to rise from USD 839.5 million in 2024 to a projected USD 1,341.7 million by 2034. This growth trajectory, representing a Compound Annual Growth Rate (CAGR) of 4.8%, underscores the increasing importance and adoption of …

Global Pediatric Diabetes Therapeutic Market to Reach USD 2612.4 Million by 2034

According to a comprehensive report by Future Market Insights (FMI), the global pediatric diabetes therapeutic market is set to experience substantial growth, with estimates projecting a rise from USD 1,633.8 million in 2024 to USD 2,612.4 million by 2034. This represents a robust compound annual growth rate (CAGR) of 4.8% over the next decade. Insulin …

Global Veterinary Rapid Test Market Set to Skyrocket, Reaching Projected to Hit USD 2870 Million by 2034

According to the latest report by Future Market Insights (FMI), the global veterinary rapid test market is poised for remarkable growth, with estimations indicating a surge to USD 942.3 million in 2024 and an impressive climb to USD 2870 million by 2034. This forecast reflects a compelling compound annual growth rate (CAGR) of 11.8% over …

Asia Pacific Loop-mediated Isothermal Amplification (LAMP) Industry Valuation Set to Total USD 409.8 Million by 2034

As per Future Market Insights’ latest analysis, the Asia Pacific loop-mediated isothermal amplification (LAMP) industry value is set to total USD 237.3 million in 2024. Further, it will exhibit a CAGR of 5.7% during the next ten years, with total industry size reaching USD 409.8 million by 2034. Several factors are propelling growth of LAMP …

Global Barbiturate Drug Market Projected to Reach USD 675.0 Million by 2034

The global barbiturate drug market value is expected to rise from USD 492.8 million in 2024 to USD 675.0 million by 2034. This market is analyzed to surge ahead at a CAGR of 3.20% over the next decade. Demand for barbiturate drugs is observing a steady increase due to their use in the treatment of …

Global Asthma Treatment Market is set to reach USD 46.0 Billion by 2034

According to Future Market Insights (FMI), the global asthma treatment market is poised for substantial growth, projected to hit USD 28.0 billion in 2024 and soar to USD 46.0 billion by 2034, with a Compound Annual Growth Rate (CAGR) of 5.1% by 2034. The burgeoning prevalence of asthma worldwide, coupled with a heightened awareness of …

Global Alexipharmic Drug Market Set to Reach USD 6.50 Billion by 2034

The escalating opioid crisis has intensified the need for effective alexipharmic drugs, leading to significant growth in the global market. Valued at an impressive USD 3.80 billion in 2024, the global alexipharmic drug market is projected to reach USD 6.50 billion by 2034, expanding at a compound annual growth rate (CAGR) of 5.40%. The legalization …